NSE ScannerOpen the scanner

Pharmaceuticals · Pharmaceuticals: Major · NSE: SOTAC · data 2026-10-30

Sotac Pharmaceuticals Limited

₹111.65+4.98% on 30 OctHealth: Strong 7.2/10

In plain words

Price: 20.1% below its 52-week high of ₹139.65.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price
₹111.65
Market cap
₹118 cr
P/E
21.4
P/B
2.1
ROE
10.3%
ROCE
17.4%
Debt / equity
0.64
Dividend yield
0.19%
1-year return
-6.1%
52-week high
₹139.65
52-week low
₹86
Operating margin
8.6%

Growth

Revenue (last 12 months)₹97 cr
Net profit (last 12 months)₹6 cr
Sales growth, 3 years (yearly)9.3%
Profit growth, 3 years (yearly)26.1%

Smart-money activity

5/100 · Weak over the last ~60 sessions

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

Is Sotac Pharmaceuticals Limited debt-free?

Its latest reported debt-to-equity ratio is 0.64.

What is Sotac Pharmaceuticals Limited's P/E ratio?

About 21.4, based on the last 12 months' earnings and a price of ₹111.65 (data 2026-10-30).

What is the 52-week high and low of Sotac Pharmaceuticals Limited?

The 52-week high is ₹139.65 and the 52-week low is ₹86.

Similar companies

Bal Pharma Limited (BALPHARMA) · Krebs Biochemicals & Industries Ltd. (KREBSBIO) · Parnax Lab Limited (PARNAXLAB) · Makers Laboratories Ltd (MAKERSL) · Alpa Laboratories Limited (ALPA)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open SOTAC in NSE Scanner →
Share on WhatsAppShare on Telegram